This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Grand Theravac Life Science (Nanjing) Co., Ltd., Grand Theravac Life Sciences (Nanjing) Co., Ltd., Jiangsu Theravac Bio-Pharmaceutical Co., Ltd.. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2026
Title: The Innovative Contributions of Yue Gu in Hepatitis B Treatments
Introduction
Yue Gu, an innovative inventor based in Nanjing, China, has made significant strides in the field of pharmaceutical preparations aimed at treating hepatitis B. With two patents to his name, his work demonstrates a commitment to improving health outcomes and advancing medical science.
Latest Patents
Yue Gu's latest patents showcase his ingenuity and focus on addressing hepatitis B. One patent details a pharmaceutical preparation that includes a solution of both hepatitis B surface antigen and core antigen, along with an oligodeoxynucleotide solution. This preparation is noted for being free of saccharide, which enhances its antigen stability and minimizes adverse reactions typically associated with aluminum adjuvants. Additionally, the preparation has shown promising results in long-term stability experiments.
His other patent involves a unique composition comprising HBsAg, HBcAg variants, and a 21-base long phosphorothioate oligonucleotide. This composition is aimed at treating HBV infections and related diseases, introducing novel therapy methods that could reshape treatment protocols.
Career Highlights
Yue Gu has been associated with reputable companies such as Jiangsu Theravac Bio-pharmaceutical Co., Ltd. and Grand Theravac Life Sciences (Nanjing) Co., Ltd. His professional journey reflects a dedication to research and development within the pharmaceutical sector, especially in addressing serious health issues like hepatitis B.
Collaborations
Throughout his career, Yue Gu has collaborated with talented individuals, including coworkers Jun Ge and Tong Zhou. These collaborations have likely enriched his research and led to the development of impactful inventions that contribute to public health.
Conclusion
Yue Gu's contributions to pharmaceutical innovation, particularly in the treatment of hepatitis B, are commendable. His patents not only highlight his skill as an inventor but also underscore the importance of continued research in combating viral infections. As medical challenges persist globally, inventors like Yue Gu play a critical role in paving the way for new therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile